Murphy & Mullick Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Murphy & Mullick Capital Management's LLY Position: Q2 2026 in Review
Murphy & Mullick Capital Management increased its Eli Lilly (LLY) stake by 0.71% in Q2 2026, buying an estimated $10.2K and bringing the position to 1,416 shares worth $1.7M. The position accounts for 1.05% of the portfolio, ranked #21.
Murphy & Mullick Capital Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Murphy & Mullick Capital Management held 1,416 shares of Eli Lilly worth $1.7M as of Q2 2026.
- Murphy & Mullick Capital Management bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
- Eli Lilly made up 1.05% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #21 holding.
- Murphy & Mullick Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.